OBIZUR

This brand name is authorized in Austria, Canada, Croatia, Estonia, Finland, France, Ireland, Italy, Lithuania, Netherlands, Poland, Romania, UK.

Active ingredients

The drug OBIZUR contains one active pharmaceutical ingredient (API):

1	Susoctocog alfa UNII 6892UQT2GK - SUSOCTOCOG ALFA
	Susoctocog alfa is a recombinant, B-domain deleted, porcine sequence Factor VIII. It is a glycoprotein. Acquired haemophilia is a rare bleeding disorder in which patients with normal Factor VIII genes develop inhibitory autoantibodies directed against Factor VIII. These autoantibodies neutralize circulating human Factor VIII thus creating a deficiency of available Factor VIII. Susoctocog alfa temporarily replaces the inhibited endogenous Factor VIII that is needed for effective haemostasis.
	Read more about Susoctocog alfa

Medication package inserts

Below package inserts are available for further reading:

Document	Type	Information Source
OBIZUR Powder and solvent for solution for injection	MPI, EU: SmPC	European Medicines Agency (EU)

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
B02BD02	Coagulation factor VIII	B Blood and blood forming organs → B02 Antihemorrhagics → B02B Vitamin K and other hemostatics → B02BD Blood coagulation factors
Discover more medicines within B02BD02

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
CA	Health Products and Food Branch	02447401
EE	Ravimiamet	1703124, 1703135, 1703146
FI	Lääkealan turvallisuus- ja kehittämiskeskus	475471
FR	Base de données publique des médicaments	65982247
GB	Medicines & Healthcare Products Regulatory Agency	326858, 326859, 326860
IT	Agenzia del Farmaco	044557015, 044557027, 044557039
LT	Valstybinė vaistų kontrolės tarnyba	1078670, 1078671, 1078672
NL	Z-Index G-Standaard, PRK	135127
PL	Rejestru Produktów Leczniczych	100358856
RO	Agenția Națională a Medicamentului și a Dispozitivelor Medicale	W66930001, W66930002, W66930003